Journals and Databases

Start a new search

Healthcare Databases Advanced Search | Help

 

Searched: Antiretroviral Therapy, Highly Active. Total records matched: 3073

Resources searched: MEDLINE from PubMed

  1. 1. Factors Associated With Lack of Viral Suppression at Delivery Among Highly Active Antiretroviral Therapy-Naive Women With HIV: A Cohort Study.

    Author(s): Katz IT, Leister E, Kacanek D, Hughes MD, Bardeguez A, Livingston E, Stek A, Shapiro DE, Tuomala R

    Citation: Annals of internal medicine, 20 January 2015, vol./is. 162/2(90-9), 0003-4819

    Publication Date: 20 January 2015

    Source: MEDLINE from PubMed

  2. 2. Clinical Challenges of Thyroid Eye Disease in HIV Positive Patients on Highly Active Antiretroviral Therapy.

    Author(s): Edmunds MR, Mellington F, Ford RL, Torlinska B, Manavi K, Boelaert K

    Citation: The Journal of clinical endocrinology and metabolism, 13 January 2015(jc20143544), 0021-972X

    Publication Date: 13 January 2015

    Source: MEDLINE from PubMed

  3. 3. [Analysis of the five-year effectiveness of highly active antiretroviral therapy among 200 HIV/AIDS patients in Jiangsu province].

    Author(s): Qiu T, Ding P, Liu X, Guo H, Fu G, Xu X, Huan X, Yang H

    Citation: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine], November 2014, vol./is. 48/11(947-52), 0253-9624

    Publication Date: November 2014

    Source: MEDLINE from PubMed

  4. 4. Associated factors of drug-drug interactions of highly active antiretroviral therapy: report from a referral center.

    Author(s): Farhoudi M, Khalili H, Karimzadeh I, Abbasian L

    Citation: Expert opinion on drug metabolism & toxicology, 05 January 2015(1-9), 1742-5255

    Publication Date: 05 January 2015

    Source: MEDLINE from PubMed

  5. 5. Outcome of highly active antiretroviral therapy in HIV- infected Indian children.

    Author(s): Mukherjee A, Shah N, Singh R, Vajpayee M, Kabra SK, Lodha R

    Citation: BMC infectious diseases, 24 December 2014, vol./is. 14/1(2),

    Publication Date: 24 December 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

    Available in fulltext at ProQuest

  6. 6. Highly-active antiretroviral therapy and oral opportunistic microorganisms in HIV-positive individuals of Thailand.

    Author(s): Arirachakaran P, Poovorawan Y, Dahlén G

    Citation: Journal of investigative and clinical dentistry, 24 December 2014, 2041-1618

    Publication Date: 24 December 2014

    Source: MEDLINE from PubMed

  7. 7. The effect of depressive symptoms and CD4 count on adherence to highly active antiretroviral therapy in sub-Saharan Africa.

    Author(s): Memiah P, Shumba C, Etienne-Mesubi M, Agbor S, Hossain MB, Komba P, Niyang M, Biadgilign S

    Citation: Journal of the International Association of Providers of AIDS Care, July 2014, vol./is. 13/4(346-52), 2325-9574

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  8. 8. Retraction: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.

    Citation: BMC research notes, 25 November 2014(868),

    Publication Date: 25 November 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

    Available in fulltext at ProQuest

  9. 9. Inter and intra-host variability of hepatitis C virus genotype 1a hypervariable envelope coding domains followed for a 4-11 year of human immunodeficiency virus coinfection and highly active antiretroviral therapy.

    Author(s): Sede M, Jones LR, Moretti F, Laufer N, Quarleri J

    Citation: Virology, 20 October 2014(19-28), 0042-6822

    Publication Date: 20 October 2014

    Source: MEDLINE from PubMed

  10. 10. Cardiac steatosis and left ventricular dysfunction in HIV-infected patients treated with highly active antiretroviral therapy.

    Author(s): Nelson MD, Szczepaniak LS, LaBounty TM, Szczepaniak E, Li D, Tighiouart M, Li Q, Dharmakumar R, Sannes G, Fan Z, Yumul R, Hardy WD, Hernandez Conte A

    Citation: JACC. Cardiovascular imaging, November 2014, vol./is. 7/11(1175-7), 1936-878X

    Publication Date: November 2014

    Source: MEDLINE from PubMed

  11. 11. Highly active antiretroviral therapy-related hepatotoxicity in human immunodeficiency virus and hepatitis C virus co-infected patients with advanced liver fibrosis in Taiwan.

    Author(s): Chou CC, Tsai HC, Wu KS, Sy CL, Chen JK, Chen YS, Lee SS

    Citation: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 01 November 2014, 1684-1182

    Publication Date: 01 November 2014

    Source: MEDLINE from PubMed

  12. 12. Efficacy of generic highly active antiretroviral therapy in HIV-1 infected individuals in Nigeria.

    Author(s): Adewumi OM, Odaibo GN, Olaleye OD

    Citation: Journal of immunoassay & immunochemistry, 01 December 2014, 1532-1819

    Publication Date: 01 December 2014

    Source: MEDLINE from PubMed

  13. 13. HIV-1 Subtype Diversity Based on Envelope C2V3 Sequences from Kenyan Patients on Highly Active Antiretroviral Therapy.

    Author(s): Kitawi RC, Nzomo T, Mwatelah RS, Aman R, Kimulwo MJ, Masankwa G, Lwembe RM, Okendo J, Ogutu B, Ochieng W

    Citation: AIDS research and human retroviruses, 25 November 2014, 0889-2229

    Publication Date: 25 November 2014

    Source: MEDLINE from PubMed

  14. 14. HIV Reservoir Dynamics in the Face of Highly Active Antiretroviral Therapy.

    Author(s): Costiniuk CT, Jenabian MA

    Citation: AIDS patient care and STDs, 20 November 2014, 1087-2914

    Publication Date: 20 November 2014

    Source: MEDLINE from PubMed

  15. 15. Apoptosis Pathways in HIV-1-Infected Patients Before and After Highly Active Antiretroviral Therapy: Relevance to Immune Recovery.

    Author(s): Pitrak DL, Novak RM, Estes R, Tschampa J, Abaya CD, Martinson J, Bradley K, Tenorio AR, Landay AL

    Citation: AIDS research and human retroviruses, 11 November 2014, 0889-2229

    Publication Date: 11 November 2014

    Source: MEDLINE from PubMed

  16. 16. Erectile Dysfunction Among HIV Patients Undergoing Highly Active Antiretroviral Therapy: Dyslipidemia as a Main Risk Factor.

    Author(s): Romero-Velez G, Lisker-Cervantes A, Villeda-Sandoval CI, Sotomayor de Zavaleta M, Olvera-Posada D, Sierra-Madero JG, Arreguin-Camacho LO, Castillejos-Molina RA

    Citation: Sexual medicine, April 2014, vol./is. 2/1(24-30),

    Publication Date: April 2014

    Source: MEDLINE from PubMed

  17. 17. Basis of selection of first and second line highly active antiretroviral therapy for HIV/AIDS on genetic barrier to resistance: a literature review.

    Author(s): Katusiime C, Ocama P, Kambugu A

    Citation: African health sciences, September 2014, vol./is. 14/3(679-81), 1680-6905

    Publication Date: September 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  18. 18. Level of Adherence and HIV RNA Suppression in the Current Era of Highly Active Antiretroviral Therapy (HAART).

    Author(s): Viswanathan S, Detels R, Mehta SH, Macatangay BJ, Kirk GD, Jacobson LP

    Citation: AIDS and behavior, 24 October 2014, 1090-7165

    Publication Date: 24 October 2014

    Source: MEDLINE from PubMed

  19. 19. The impact of comorbid clinical depression on the health-related quality of life of adults on highly active antiretroviral therapy in maiduguri, northeastern Nigeria.

    Author(s): Wakawa IA, Said JM, Abba WM, Shehu S, Rabbebe IB, Beida O

    Citation: Indian journal of psychological medicine, October 2014, vol./is. 36/4(408-17), 0253-7176

    Publication Date: October 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at ProQuest

  20. 20. Prevalence of anemia before and after initiation of highly active antiretroviral therapy among HIV positive patients in Northwest Ethiopia: a retrospective study.

    Author(s): Tesfaye Z, Enawgaw B

    Citation: BMC research notes, 22 October 2014(745),

    Publication Date: 22 October 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

    Available in fulltext at ProQuest

  21. 21. Lipodystrophy syndrome among HIV infected children on highly active antiretroviral therapy in northern India.

    Author(s): Bhutia E, Hemal A, Yadav TP, Ramesh KL

    Citation: African health sciences, June 2014, vol./is. 14/2(408-13), 1680-6905

    Publication Date: June 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  22. 22. Atherogenic index of plasma in highly active antiretroviral therapy-naïve patients with human immunodeficiency virus infection in Southeast Nigeria.

    Author(s): Onyedum CC, Young EE, Iroezindu MO, Chukwuka CJ, Nwagha UI

    Citation: Indian journal of endocrinology and metabolism, September 2014, vol./is. 18/5(631-6), 2230-8210

    Publication Date: September 2014

    Source: MEDLINE from PubMed

  23. 23. Influence of highly-active antiretroviral therapy on the subgingival biofilm in HIV-infected patients.

    Author(s): Jordan RA, Lucaciu A, Zimmer S

    Citation: Journal of investigative and clinical dentistry, 06 October 2014, 2041-1618

    Publication Date: 06 October 2014

    Source: MEDLINE from PubMed

  24. 24. Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients.

    Author(s): Duro M, Rebelo I, Barreira S, Sarmento-Castro R, Medeiros R, Almeida C

    Citation: International journal of STD & AIDS, 02 October 2014, 0956-4624

    Publication Date: 02 October 2014

    Source: MEDLINE from PubMed

  25. 25. Multicentric Castleman's Disease and Kaposi's Sarcoma in a HIV-Positive Patient on Highly Active Antiretroviral Therapy.

    Author(s): Ortega L, Cooper CJ, Otoukesh S, Mojtahedzadeh M, Didia CS, Torabi A, Nahleh Z

    Citation: Rare tumors, 30 July 2014, vol./is. 6/3(5480), 2036-3605

    Publication Date: 30 July 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  26. 26. Stimulant use and progression to AIDS or mortality after the initiation of highly active antiretroviral therapy.

    Author(s): Carrico AW, Shoptaw S, Cox C, Stall R, Li X, Ostrow DG, Vlahov D, Plankey MW

    Citation: Journal of acquired immune deficiency syndromes (1999), 15 December 2014, vol./is. 67/5(508-13), 1525-4135

    Publication Date: 15 December 2014

    Source: MEDLINE from PubMed

  27. 27. Selected micronutrient levels and response to highly active antiretroviral therapy (HAART) among HIV/AIDS patients attending a teaching Hospital in Addis Ababa, Ethiopia.

    Author(s): Eshetu A, Tsegaye A, Petros B

    Citation: Biological trace element research, December 2014, vol./is. 162/1-3(106-12), 0163-4984

    Publication Date: December 2014

    Source: MEDLINE from PubMed

  28. 28. Changes in the incidence of severe thrombocytopenia and its predisposing conditions in HIV-infected patients since the introduction of highly active antiretroviral therapy.

    Author(s): Franzetti M, Adorni F, Oreni L, Van Den Bogaart L, Resnati C, Milazzo L, Antinori S, Galli M, Ridolfo AL

    Citation: Journal of acquired immune deficiency syndromes (1999), 15 December 2014, vol./is. 67/5(493-8), 1525-4135

    Publication Date: 15 December 2014

    Source: MEDLINE from PubMed

  29. 29. Vitamin E concentrations in adults with HIV/AIDS on highly active antiretroviral therapy.

    Author(s): Itinoseki Kaio DJ, Rondó PH, Luzia LA, Souza JM, Firmino AV, Santos SS

    Citation: Nutrients, 15 September 2014, vol./is. 6/9(3641-52),

    Publication Date: 15 September 2014

    Source: MEDLINE from PubMed

  30. 30. Virtual Elimination of Mother-to-Child Transmission of Human Immunodeficiency Virus in Mothers on Highly Active Antiretroviral Therapy in Enugu, South-Eastern Nigeria.

    Author(s): Okafor I, Ugwu E, Obi S, Odugu B

    Citation: Annals of medical and health sciences research, July 2014, vol./is. 4/4(615-8), 2141-9248

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  31. 31. Mortality and its predictors among highly active antiretroviral therapy naive hiv-infected individuals: data from prospective cohort study in Ukraine.

    Author(s): Zhyvytsia D

    Citation: Georgian medical news, July 2014(69-74), 1512-0112

    Publication Date: July 2014

    Source: MEDLINE from PubMed

  32. 32. Prevalence and correlates of cytopenias in HIV-infected adults initiating highly active antiretroviral therapy in Uganda.

    Author(s): Kyeyune R, Saathoff E, Ezeamama AE, Löscher T, Fawzi W, Guwatudde D

    Citation: BMC infectious diseases, 10 September 2014(496),

    Publication Date: 10 September 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

    Available in fulltext at ProQuest

  33. 33. High-level human herpesvirus-8 viremia and multicentric Castleman's disease following initiation of highly active antiretroviral therapy.

    Author(s): Lumley S, Madge S, Nugent D, Ainsworth J, Dervisevic S, Schmitt C, Schulz TF, Johnson MA, Cwynarski K, Webster DP

    Citation: AIDS (London, England), 17 July 2014, vol./is. 28/11(1698-700), 0269-9370

    Publication Date: 17 July 2014

    Source: MEDLINE from PubMed

  34. 34. Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy-era. A literature analysis.

    Author(s): Gaitán-Cepeda LA, Sánchez-Vargas O, Castillo N

    Citation: International journal of STD & AIDS, 25 August 2014, 0956-4624

    Publication Date: 25 August 2014

    Source: MEDLINE from PubMed

  35. 35. Adherence to highly active antiretroviral therapy and associated factors among children at the University of Gondar Hospital and Gondar Poly Clinic, Northwest Ethiopia: a cross-sectional institutional based study.

    Author(s): Dachew BA, Tesfahunegn TB, Birhanu AM

    Citation: BMC public health, 26 August 2014(875),

    Publication Date: 26 August 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at ProQuest

    Available in fulltext at National Library of Medicine

    Available in fulltext at BioMedCentral

  36. 36. Magnetic resonance imaging evaluation of lipodystrophy in HIV-positive patients receiving highly active antiretroviral therapy.

    Author(s): Eichler K, Bickel T, Klauke S, Eisen J, Vogl T, Zangos S

    Citation: International journal of STD & AIDS, 18 August 2014, 0956-4624

    Publication Date: 18 August 2014

    Source: MEDLINE from PubMed

  37. 37. Healthy HIV-1-Infected Individuals on Highly Active Antiretroviral Therapy Harbor HIV-1 in Their Alveolar Macrophages.

    Author(s): Cribbs SK, Lennox J, Caliendo AM, Brown LA, Guidot DM

    Citation: AIDS research and human retroviruses, January 2015, vol./is. 31/1(64-70), 0889-2229

    Publication Date: January 2015

    Source: MEDLINE from PubMed

  38. 38. The immune pathogenesis of immune reconstitution inflammatory syndrome associated with highly active antiretroviral therapy in AIDS.

    Author(s): Zheng Y, Zhou H, He Y, Chen Z, He B, He M

    Citation: AIDS research and human retroviruses, December 2014, vol./is. 30/12(1197-202), 0889-2229

    Publication Date: December 2014

    Source: MEDLINE from PubMed

  39. 39. Emerging trends of HIV drug resistance in Chinese HIV-infected patients receiving first-line highly active antiretroviral therapy: a systematic review and meta-analysis.

    Author(s): Liu H, Ma Y, Su Y, Smith MK, Liu Y, Jin Y, Gu H, Wu J, Zhu L, Wang N

    Citation: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 15 November 2014, vol./is. 59/10(1495-502), 1058-4838

    Publication Date: 15 November 2014

    Source: MEDLINE from PubMed

  40. 40. Body mass index changes during highly active antiretroviral therapy in Nigeria.

    Author(s): Denue BA, Ikunaiye PN, Denue CB

    Citation: Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 09 January 2014(S89-97), 1020-3397

    Publication Date: 09 January 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at ProQuest

  41. 41. Prevalence of transmitted HIV-1 drug resistance remains low in Guangxi, China, eight years after scale-up of highly-active antiretroviral therapy.

    Author(s): Li G, Liang S, Harrison TJ, Tang Z, Shen Z, Wang X, Wu X, Liu W, Liang F, Feng L, Yang J, Fang Z

    Citation: Intervirology, 2014, vol./is. 57/5(270-6), 0300-5526

    Publication Date: 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at ProQuest

    Available in fulltext at Karger Medical and Scientific Publishers; Note: ; Collection notes: Academic-License: Only available from an NHS networked computer

  42. 42. Highly active antiretroviral therapy-related mechanisms of endothelial and platelet function alterations.

    Author(s): Gresele P, Falcinelli E, Momi S, Francisci D, Baldelli F

    Citation: Reviews in cardiovascular medicine, 2014(S9-20), 1530-6550

    Publication Date: 2014

    Source: MEDLINE from PubMed

  43. 43. A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era.

    Author(s): D'Ascenzo F, Quadri G, Cerrato E, Calcagno A, Omedè P, Grosso Marra W, Abbate A, Bonora S, Biondi Zoccai G, Moretti C, Gaita F

    Citation: Journal of cardiovascular medicine (Hagerstown, Md.), 28 June 2014, 1558-2027

    Publication Date: 28 June 2014

    Source: MEDLINE from PubMed

  44. 44. A comparison of maternal anemia between HIV infected pregnant women receiving zidovudine-based and zidovudine-free highly active Antiretroviral therapy (HAART).

    Author(s): Lertcheewakarn P, Tongprasert F

    Citation: Journal of the Medical Association of Thailand = Chotmaihet thangphaet, April 2014, vol./is. 97/4(361-8), 0125-2208

    Publication Date: April 2014

    Source: MEDLINE from PubMed

  45. 45. Dermatological manifestations of human immunodeficiency virus/acquired immunodeficiency syndrome in era of highly active antiretroviral therapy.

    Author(s): Bosamiya SS, Vaishnani JB, Momin AM

    Citation: Indian journal of sexually transmitted diseases, January 2014, vol./is. 35/1(73-5), 0253-7184

    Publication Date: January 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at ProQuest

  46. 46. Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: a cross sectional study.

    Author(s): Tadesse WT, Mekonnen AB, Tesfaye WH, Tadesse YT

    Citation: BMC pharmacology & toxicology, 23 June 2014(32),

    Publication Date: 23 June 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at BioMedCentral

    Available in fulltext at ProQuest

  47. 47. Impacts of highly active antiretroviral therapy (HAART) on metabolic status of patients with AIDS: What happens from the initiation of AIDS to the initiation of treatment?

    Author(s): Abdollahi A, Shoar S, Jafari S, Shoar N

    Citation: Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, March 2014, vol./is. 19/3(246-50), 1735-1995

    Publication Date: March 2014

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at ProQuest

  48. 48. Predicting mortality in HIV-infected children initiating highly active antiretroviral therapy in a resource-deprived setting.

    Author(s): Nugent J, Edmonds A, Lusiama J, Thompson D, Behets F

    Citation: The Pediatric infectious disease journal, November 2014, vol./is. 33/11(1148-55), 0891-3668

    Publication Date: November 2014

    Source: MEDLINE from PubMed

  49. 49. Seroprevalence of HBV and HIV co-infection in children and outcomes following highly active antiretroviral therapy (HAART) in Uyo, South-South Nigeria.

    Author(s): Ikpeme EE, Etukudo OM, Ekrikpo UE

    Citation: African health sciences, December 2013, vol./is. 13/4(955-61), 1680-6905

    Publication Date: December 2013

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine

  50. 50. Roles of family dynamics on adherence to highly active antiretroviral therapy among people living with HIV/AIDS at a tertiary hospital in Osogbo, south-west Nigeria.

    Author(s): Afolabi BA, Afolabi MO, Afolabi AA, Odewale MA, Olowookere SA

    Citation: African health sciences, December 2013, vol./is. 13/4(920-6), 1680-6905

    Publication Date: December 2013

    Source: MEDLINE from PubMed

    Full Text:

    Available in fulltext at National Library of Medicine


Results Selected
No results selected.

Output Format
Choose output document format.
Display Format
Choose output fields.
Actions
Display, save or email results with selected fields and output formats.